« Previous
Next »
Titles
- M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use1
- M4E(R2): the CTD--efficacy1
- M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk1
- MAT for hospitalized patients1
- MAT for opioid use disorder: overcoming objections1
- MAT in community health centers1
- MAT in the emergency department: FAQ1
- MRI screening: what's in your pocket?1
- Making a little go a long way: the case of Sasha Bruce Youthwork1
- Making quality matter in Medi-Cal managed care: how other states hold health plans financially accountable for performance1
- Making the case for prevention: why Washington's Accountable Communities of Health should pursue Domain 3D chronic disease prevention projects1
- Managed care1
- Management of stable angina: a national clinical guideline1
- Mandated benefits1
- Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff1
- Many Medicaid-enrolled children who were treated for ADHD did not receive recommended followup care1
- Many adults targeted by Medicaid work requirements face barriers to sustained employment1
- Mapping pre-existing conditions across the U.S1
- Marketing clearance of diagnostic ultrasound systems and transducers: guidance for industry and Food and Drug Administration staff1
- Maternity care in California: a bundle of data1